In the British Journal of Cancer this week, researchers in Germany report their comparison of blood-based inflammatory markers and fecal occult blood tests for screening patients for non-invasive colorectal cancer. The team analyzed C-reactive protein, serum CD26, complement C3a anaphylatoxin, and TIMP-1 levels in blood and fecal samples of 179 colorectal cancer patients, 193 people with advanced adenoma, and 225 people free of neoplasm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.